News

January has been a month of change for Abbott, and a senior medical devices analyst from GlobalData asserts that the company’s latest cardiac diagnostics product represents the first step in a...

Abbot Vascualr Architect Stat Blood Testing Point-of-Care Testing

An estimated 17 million people throughout the world die annually of cardiovascular diseases, specifically heart attacks or strokes. Time is a critical factor in diagnosing and treating people who...

Accumetrics VerifyNow II CE mark Antiplatelet Therapy

Accumetrics Inc. announced that its next generation VerifyNow II System has achieved CE marking for point-of-care measurement of platelet reactivity to antiplatelet agents. This marks the...

V-Chip Methodist Hospital Research Institute MD Anderson Cancer Center

A new device about the size of a business card could allow health care providers to test blood for insulin and other...

December 19, 2012 — The latest generation of diagnostic tests in development is expected to provide information that will be important to patient outcomes, potentially reducing the time to...

November 20, 2012 — The American College of Cardiology (ACC), in collaboration with several other professional societies, has released the first comprehensive consensus document outlining clinical...

CoaguChek XS Plus System Point of Care Testing Blood Testing

The U.S. Food and Drug Administration (FDA) has granted Clinical Laboratory Improvement Amendments (CLIA)-waived status to the Roche CoaguChek XS Plus system. The point-of-care...

Type 2 Diabetis Mellulitis Blood Testing Cardiac Diagnostics

LipoScience Inc., a highly innovative diagnostic company that is advancing patient care by developing high value proprietary blood tests using nuclear magnetic resonance (NMR) technology,...

September 28, 2012 — Accumetrics Inc., developer of the VerifyNow System, the first rapid and easy-to-use point-of-...

August 30, 2012 — Copeptin predicts prognosis in patients with heart failure, according to research presented at the European Society of Cardiology (ESC) congress this week Professor Stefan Störk...

August 9, 2012 — CardioDx Inc. announced that Palmetto GBA, a national contractor that administers Medicare benefits, has established coverage for the company’s Corus CAD gene...

July 26, 2012 — Transgenomic Inc. has announced that National Government Services, the designated Medicare fiscal intermediary in Connecticut, has confirmed coverage for its proprietary...

 

July 16, 2012 — LipoScience Inc., an in vitro diagnostic company developing clinical diagnostic tests using nuclear magnetic resonance (NMR) technology, announced...

July 16, 2012 — The U.S. Food and Drug Administration (FDA) notified healthcare professionals of a Class I recall of Alere Triage products. Identified lots may have significantly decreased...

Over the past decade there have been several advancements in prothrombin time (PT)/international normalized ration (INR) point-of-care testing (POCT) devices. This is usually performed at an...

June 11, 2012 — Critical Diagnostics, a U.S.-based biomarker company focused on cardiovascular diseases, and Health Diagnostic Laboratory Inc. (HDL) announced an agreement under which HDL will...

May 23, 2012 — Accumetrics Inc., developer of the VerifyNow System, the first rapid and easy-to-use point-of-care system for measuring platelet reactivity to multiple antiplatelet agents,...

March 23, 2012 — New findings from a research study led by Scripps Translational Science Institute (STSI), a collaborative program between Scripps Health and the Scripps Research Institute (TSRI...

March 23, 2012 — Researchers using the VAP (vertical auto profile) Cholesterol Test to isolate lipid subfractions and assess a new anti-flushing agent have reported significant baseline reductions...

March 8, 2012 — Transgenomic Inc. announced the publication of a new study by researchers at Vanderbilt University that further validates the role of both genes found in the company’s PGxPredict:...